Pancreatic Cancer Research

ResearcherJiangsu UniversityActive in the last 2 years

Min‐Bin Chen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1453-8664; OpenAlex author ID A5074387878, A5135804868. Sources: OpenAlex.

Their work

Papers
5 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
11
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 2 papers

Papers 5

  1. Characterization of ADGRG6 as a potential molecular oncotarget of pancreatic cancer. Last author DOI 10.1038/s41419-026-08766-2↗
  2. Identification of PRRG1 as a possible molecular target of pancreatic cancer. Last author DOI 10.1038/s41419-026-08832-9↗
  3. Identification of matrix-remodeling associated 5 as a possible molecular oncotarget of pancreatic cancer. Co-author DOI 10.1038/s41419-023-05684-5↗
  4. Identification of phosphoenolpyruvate carboxykinase 1 as a potential therapeutic target for pancreatic cancer. Last author DOI 10.1038/s41419-021-04201-w↗
  5. Prognostic Value of SPARC in Patients with Pancreatic Cancer: A Systematic Review and Meta-Analysis. Co-author DOI 10.1371/journal.pone.0145803↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaoren Zhu · 4 shared papers, 2021–2026 · strength 1.02
  2. Qian-Hui Gu · 2 shared papers, 2026 · strength 0.67
  3. Liu Y · 2 shared papers, 2026 · strength 0.67
  4. Zhen-yu Ye · 2 shared papers, 2023–2026 · strength 0.48
  5. Jia-Jie Chen · 1 shared paper, 2026 · strength 0.39
  6. Shi-qing Peng · 2 shared papers, 2021–2023 · strength 0.35
  7. Jian-Zhuo Jiang · 1 shared paper, 2026 · strength 0.28
  8. Yifan Zhang · 1 shared paper, 2023 · strength 0.20
  9. Yuan-yuan Liu · 1 shared paper, 2021 · strength 0.15
  10. Hou-zhong Ding · 1 shared paper, 2016 · strength 0.06
  11. Wei Han · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.